tiprankstipranks
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ:TARS
US Market
TARS
Tarsus Pharmaceuticals
RESEARCH TOOLSreports
Want to see TARS full AI Analyst Report?

Tarsus Pharmaceuticals (TARS) Income Statement

270 Followers

Tarsus Pharmaceuticals Income Statement

Last quarter (Q1 2026), Tarsus Pharmaceuticals's total revenue was $162.05M, an increase of 106.87% from the same quarter last year. In Q1, Tarsus Pharmaceuticals's net income was $-6.97M. See Tarsus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 451.36M$ 182.95M$ 17.45M$ 25.82M$ 57.03M
Gross Profit
$ 420.68M$ 170.13M$ 15.85M$ 24.86M$ 54.95M
Operating Expenses
$ 491.64M$ 290.70M$ 159.01M$ 87.57M$ 67.11M
Depreciation and Amortization
$ 1.82M$ 1.23M$ 877.00K$ 326.00K$ 312.00K
EBITDA
$ -53.61M$ -106.48M$ -131.67M$ -59.70M$ -13.46M
Operating Income
$ -70.97M$ -120.57M$ -143.16M$ -62.71M$ -12.16M
Other Income/Expenses
$ 6.61M$ 5.01M$ 7.26M$ 617.00K$ -1.61M
Pretax Income
$ -64.36M$ -115.55M$ -135.89M$ -62.09M$ -13.77M
Net Income
$ -66.42M$ -115.55M$ -135.89M$ -62.09M$ -13.83M
Per Share Metrics
Basic EPS
$ -1.59$ -3.07$ -4.62$ -2.52$ -0.67
Diluted EPS
$ -1.59$ -3.07$ -4.62$ -2.52$ -0.67
Weighted Average Shares Outstanding
 41.78M 37.60M 29.38M 24.62M 20.55M
Weighted Average Shares Outstanding (Diluted)
 41.78M 37.60M 29.38M 24.62M 20.55M
Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History